Wellington Management Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.17M Buy
158,052
+9,974
+7% +$137K ﹤0.01% 1556
2025
Q1
$1.64M Buy
148,078
+1,125
+0.8% +$12.4K ﹤0.01% 1596
2024
Q4
$1.57M Buy
146,953
+9,653
+7% +$103K ﹤0.01% 1620
2024
Q3
$1.74M Sell
137,300
-18,778
-12% -$238K ﹤0.01% 1565
2024
Q2
$2.62M Buy
156,078
+19,337
+14% +$324K ﹤0.01% 1455
2024
Q1
$2.05M Buy
136,741
+32,141
+31% +$482K ﹤0.01% 1516
2023
Q4
$1.57M Buy
104,600
+34,537
+49% +$518K ﹤0.01% 1533
2023
Q3
$982K Buy
+70,063
New +$982K ﹤0.01% 1614
2022
Q1
Sell
-238,008
Closed -$2.26M 2228
2021
Q4
$2.26M Sell
238,008
-79,292
-25% -$754K ﹤0.01% 1636
2021
Q3
$5.34M Sell
317,300
-1,072,325
-77% -$18M ﹤0.01% 1495
2021
Q2
$21.2M Sell
1,389,625
-264,958
-16% -$4.05M ﹤0.01% 1085
2021
Q1
$32.2M Sell
1,654,583
-186,054
-10% -$3.62M 0.01% 940
2020
Q4
$33.2M Sell
1,840,637
-155,353
-8% -$2.8M 0.01% 900
2020
Q3
$38.5M Sell
1,995,990
-5,602
-0.3% -$108K 0.01% 768
2020
Q2
$52.3M Buy
2,001,592
+906,207
+83% +$23.7M 0.01% 691
2020
Q1
$19.5M Sell
1,095,385
-126,012
-10% -$2.25M 0.01% 880
2019
Q4
$40.8M Sell
1,221,397
-95,869
-7% -$3.2M 0.01% 814
2019
Q3
$31.4M Sell
1,317,266
-99,906
-7% -$2.38M 0.01% 848
2019
Q2
$50.9M Sell
1,417,172
-35,065
-2% -$1.26M 0.01% 751
2019
Q1
$53.6M Buy
1,452,237
+479,083
+49% +$17.7M 0.01% 715
2018
Q4
$41.9M Sell
973,154
-20,632
-2% -$888K 0.01% 763
2018
Q3
$46.9M Buy
993,786
+7,126
+0.7% +$337K 0.01% 822
2018
Q2
$49.1M Buy
986,660
+46,785
+5% +$2.33M 0.01% 799
2018
Q1
$46.7M Buy
939,875
+420,785
+81% +$20.9M 0.01% 806
2017
Q4
$19.3M Buy
519,090
+229,828
+79% +$8.55M ﹤0.01% 1079
2017
Q3
$9.12M Sell
289,262
-463,478
-62% -$14.6M ﹤0.01% 1288
2017
Q2
$13.6M Buy
+752,740
New +$13.6M ﹤0.01% 1131